GL1X · GenesisL1 explorer

MolNFT v1 · #34781 · protein

Crystal form II: high resolution crystal structure of the complex of the hydrolytic antibody Fab 6D9 and a transition-state analog

2DQU · Immunoglobulin 6D9: “Crystal form II: high resolution crystal structure of the complex of the hydrolytic antibody Fab 6D9 and a…”. X-ray diffraction, 1 ligand (CPD), 5 pockets (best druggability 0.63). MolNFT v1 #34781 on GenesisL1…

PDB
2DQU
Type
protein
Length
441 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Immunoglobulin 6D9
Ligands
CPD
Pockets
5 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LImmunoglobulin 6D9protein2197% helix, 51% strand—
HImmunoglobulin 6D9protein2227% helix, 52% strand—

Ligands and binding sites

  • CPD · [1-(3-dimethylamino-propyl)-3-ethyl-ureido]-[4-(2,2,2-trifluoro-acetylamino)-benzyl]phosphinic acid-2-(2,2-dihydro-acetylamino)-3-hydroxy-1-(4-nitrophenyl)-propyl ester · ligand · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11800.630.8423CPD
23630.570.7548empty
31490.430.7525empty
4650.290.7421empty
5580.270.7417empty

Interfaces

1 interface between chains.

  • L–H · 2033 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 2DQU · Crystal form II: high resolution crystal structure of the complex of the hydrolytic… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.